Our website uses cookies to distinguish you from other users of our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on ‘Accept’ you consent to our cookie policy. However, you may visit ‘Cookie Settings’ to provide a controlled consent.

Accept

Year: 2019

NSV News Portfolio News
Oppilan Pharma Initiates Phase 1 Clinical Study with OPL-002
January 7, 2019

Oppilan Pharma Initiates Phase 1 Clinical Study with OPL-002

A novel S1P1 modulator for the treatment of inflammatory bowel disease ENCINITAS, California and Cambridge, United Kingdom, January 7, 2019 – Oppilan Pharma Ltd, a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics for the treatment of autoimmune diseases, today announced that it has completed dosing of the

Read More
ProterixBio, Inc. presenting at Biotech Showcase™ 2019
January 4, 2019

ProterixBio, Inc. presenting at Biotech Showcase™ 2019

  ProterixBio, Inc. will be attending Biotech Showcase™ 2019, to be held January 7-9th at the Hilton San Francisco Union Square. Biotech Showcase™, along with the Digital Medicine and Medtech Showcase, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an

Read More
Cookie Policy Website powered by 100% renewable energy Privacy Policy